Latest Trials

EudraCT Number: 2006-005772-41 Sponsor Protocol Number: LIMIT phase 2 version 1.0 Start Date: 2006-12-05
Sponsor Name: investigator-driven research: Erasmus MC, Neurovascular Section
Full Title: LIMIT: Lowering the Incidence of vascular complications with Metformin in patients with Impaired glucose tolerance and a recent TIA or minor ischemic stroke: a phase 2, randomized, controlled trial
Medical condition: Patients with impaired glucose tolerance and a recent TIA or minor ischemic stroke
Disease: Version SOC Term Classification Code Term Level
8.1 10052426 Glucose intolerance LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-004432-70 Sponsor Protocol Number: ema1-profilC-2006 Start Date: 2006-12-04
Sponsor Name: AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
Full Title: A multicenter phase II study to evaluate the safety, tolerability and efficacy of caspofungin as prophylactic treatment of invasive fungal infections in patients with acute leukemia undergoing ind...
Medical condition: neutropenia
Disease: Version SOC Term Classification Code Term Level
6.1 10049085 PT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-003561-13 Sponsor Protocol Number: cro488 Start Date: 2006-12-04
Sponsor Name: imperial college
Full Title: Reversal of steroid insensitivity in COPD by theophylline
Medical condition: Chronic Obstructive Pulmonary Disease (COPD)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2006-003149-17 Sponsor Protocol Number: NSCLC-TRT-Avastin Start Date: 2006-12-04
Sponsor Name: VU University Medical Center
Full Title: Phase I study of concurrent with involved-field thoracic radiotherapy for inoperable non-squamous cell lung cancer, followed by both concurrent and maintenance Bevacizumab
Medical condition: Patients with locally advanced (stages II-IIIB) non-small cell lung cancer who are eligible for high-dose radiotherapy following the completion of induction systemic chemotherapy.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-002832-10 Sponsor Protocol Number: FOXA-1 Start Date: 2006-12-04
Sponsor Name: Haukeland University Hospital
Full Title: Liitännäishoitona annetun oksaliplatiinipohjaisen solusalpaajahoidon jälkeinen hedelmällisyys kolorektaalisyöpäpotilailla. Pohjoismainen prospektiivinen tutkimus. Fertility in colorectal cancer pat...
Medical condition: Kolorektaalisyöpä, colorectal cancer
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: FI (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-001763-36 Sponsor Protocol Number: CSPP100A2347 Start Date: 2006-12-04
Sponsor Name: Novartis Pharma Services AG
Full Title: A randomized, double-blind, parallel-group, placebo-controlled, multinational clinical trial to evaluate the efficacy of Aliskiren and valsartan versus placebo in lowering levels on NT-proBNP in st...
Medical condition: Hypertension
Disease: Version SOC Term Classification Code Term Level
Population Age: Gender: Male, Female
Trial protocol: NL (Completed) SE (Completed) CZ (Completed) BE (Completed) DE (Completed) HU (Completed)
Trial results: View results
EudraCT Number: 2006-004632-69 Sponsor Protocol Number: P060309 Start Date: 2006-12-04
Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
Full Title: Polymorphismes du gène codant pour le cytochrome 2C19 et réponse au clopidogrel chez le sujet sain
Medical condition: volontaire sain
Disease: Version SOC Term Classification Code Term Level
8.1 10043414 Therapeutic response decreased PT
Population Age: Adults Gender: Male
Trial protocol: FR (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-002060-26 Sponsor Protocol Number: 1401201 Start Date: 2006-12-04
Sponsor Name: Intendis GmbH
Full Title: A double-blind, randomized, vehicle-controlled, 6-week exploratory multicenter pilot study of the efficacy and safety of Azelaic Acid (AzA) 15% gel in the topical treatment of mild to moderate seb...
Medical condition: Patients with mild to moderate seborrheic dermatitis of the facial area and meeting the specific eligibility criteria
Disease: Version SOC Term Classification Code Term Level
8.1 10012488 Dermatitis seborrheic LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2006-004465-33 Sponsor Protocol Number: Cox052006 Start Date: 2006-12-04
Sponsor Name: Eero Kaasinen
Full Title: Oral Celecoxib combined with BCG instillation therapy in treatment of carcinoma in situ (CIS), TaG3 and T1 disease of urinary bladder
Medical condition: invasive bladder cancer
Disease: Version SOC Term Classification Code Term Level
8.1 10005014 Bladder carcinoma LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-003577-27 Sponsor Protocol Number: A6631007 Start Date: 2006-12-01
Sponsor Name: Pfizer Luxembourg SARL Branch Office Estonia
Full Title: A 12-WEEK, PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF PH-797804, ADMINISTERED ORALLY ONCE DAILY IN SUBJECTS WITH ACTIVE...
Medical condition: Treatment of rheumatoid arthritis (RA)
Disease: Version SOC Term Classification Code Term Level
8.1 10039073 Rheumatoid arthritis LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: EE (Completed) CZ (Completed) ES (Completed)
Trial results: View results

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe